日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/02/21 | 4,405 | 4,440 | 4,405 | 4,405 | -15 | -0.3% | 1,500 |
| 2018/02/20 | 4,405 | 4,425 | 4,405 | 4,420 | -25 | -0.6% | 700 |
| 2018/02/19 | 4,375 | 4,460 | 4,375 | 4,445 | +70 | +1.6% | 1,200 |
| 2018/02/16 | 4,320 | 4,375 | 4,320 | 4,375 | +60 | +1.4% | 1,300 |
| 2018/02/15 | 4,375 | 4,440 | 4,305 | 4,315 | -50 | -1.1% | 7,200 |
| 2018/02/14 | 4,390 | 4,425 | 4,365 | 4,365 | -25 | -0.6% | 4,300 |
| 2018/02/13 | 4,445 | 4,460 | 4,390 | 4,390 | -5 | -0.1% | 2,300 |
| 2018/02/09 | 4,490 | 4,490 | 4,395 | 4,395 | -110 | -2.4% | 5,700 |
| 2018/02/08 | 4,560 | 4,570 | 4,505 | 4,505 | -55 | -1.2% | 4,100 |
| 2018/02/07 | 4,645 | 4,685 | 4,560 | 4,560 | -50 | -1.1% | 8,400 |
| 2018/02/06 | 4,695 | 4,705 | 4,605 | 4,610 | -140 | -2.9% | 9,100 |
| 2018/02/05 | 4,750 | 4,775 | 4,730 | 4,750 | -10 | -0.2% | 2,700 |
| 2018/02/02 | 4,755 | 4,800 | 4,740 | 4,760 | +35 | +0.7% | 4,300 |
| 2018/02/01 | 4,755 | 4,755 | 4,720 | 4,725 | +15 | +0.3% | 1,300 |
| 2018/01/31 | 4,745 | 4,745 | 4,700 | 4,710 | -15 | -0.3% | 3,500 |
| 2018/01/30 | 4,790 | 4,790 | 4,680 | 4,725 | -50 | -1% | 13,700 |
| 2018/01/29 | 4,810 | 4,810 | 4,775 | 4,775 | -45 | -0.9% | 3,900 |
| 2018/01/26 | 4,815 | 4,835 | 4,815 | 4,820 | ±0 | ±0% | 1,100 |
| 2018/01/25 | 4,810 | 4,825 | 4,805 | 4,820 | -15 | -0.3% | 1,000 |
| 2018/01/24 | 4,845 | 4,845 | 4,815 | 4,835 | -10 | -0.2% | 1,100 |
| 2018/01/23 | 4,825 | 4,845 | 4,820 | 4,845 | +30 | +0.6% | 1,600 |
| 2018/01/22 | 4,875 | 4,875 | 4,815 | 4,815 | -65 | -1.3% | 2,200 |
| 2018/01/19 | 4,835 | 4,880 | 4,830 | 4,880 | +45 | +0.9% | 1,300 |
| 2018/01/18 | 4,850 | 4,875 | 4,835 | 4,835 | -15 | -0.3% | 3,200 |
| 2018/01/17 | 4,870 | 4,875 | 4,850 | 4,850 | -40 | -0.8% | 1,400 |
| 2018/01/16 | 4,865 | 4,900 | 4,840 | 4,890 | +25 | +0.5% | 2,400 |
| 2018/01/15 | 4,900 | 4,900 | 4,850 | 4,865 | +35 | +0.7% | 2,200 |
| 2018/01/12 | 4,830 | 4,840 | 4,795 | 4,830 | +5 | +0.1% | 5,600 |
| 2018/01/11 | 4,885 | 4,885 | 4,815 | 4,825 | -45 | -0.9% | 4,600 |
| 2018/01/10 | 4,790 | 4,945 | 4,785 | 4,870 | +75 | +1.6% | 8,100 |
| 2018/01/09 | 4,800 | 4,800 | 4,780 | 4,795 | -10 | -0.2% | 3,800 |
| 2018/01/05 | 4,790 | 4,820 | 4,785 | 4,805 | +5 | +0.1% | 1,900 |
| 2018/01/04 | 4,760 | 4,810 | 4,760 | 4,800 | +55 | +1.2% | 2,100 |
| 2017/12/29 | 4,760 | 4,770 | 4,745 | 4,745 | -15 | -0.3% | 1,000 |
| 2017/12/28 | 4,745 | 4,760 | 4,745 | 4,760 | ±0 | ±0% | 1,500 |
| 2017/12/27 | 4,770 | 4,830 | 4,760 | 4,760 | -15 | -0.3% | 1,900 |
| 2017/12/26 | 4,800 | 4,825 | 4,730 | 4,775 | -55 | -1.1% | 9,000 |
| 2017/12/25 | 4,825 | 4,870 | 4,815 | 4,830 | -50 | -1% | 3,700 |
| 2017/12/22 | 4,885 | 4,910 | 4,870 | 4,880 | -5 | -0.1% | 3,600 |
| 2017/12/21 | 4,890 | 4,890 | 4,860 | 4,885 | -5 | -0.1% | 2,100 |
| 2017/12/20 | 4,875 | 4,900 | 4,875 | 4,890 | +35 | +0.7% | 2,100 |
| 2017/12/19 | 4,935 | 4,935 | 4,855 | 4,855 | -100 | -2% | 5,600 |
| 2017/12/18 | 4,960 | 4,975 | 4,945 | 4,955 | -5 | -0.1% | 2,600 |
| 2017/12/15 | 4,935 | 4,980 | 4,925 | 4,960 | -10 | -0.2% | 3,400 |
| 2017/12/14 | 4,945 | 4,970 | 4,940 | 4,970 | -5 | -0.1% | 3,300 |
| 2017/12/13 | 4,960 | 4,990 | 4,950 | 4,975 | +20 | +0.4% | 2,300 |
| 2017/12/12 | 4,970 | 4,980 | 4,955 | 4,955 | -35 | -0.7% | 1,800 |
| 2017/12/11 | 4,960 | 4,990 | 4,960 | 4,990 | +15 | +0.3% | 2,700 |
| 2017/12/08 | 4,945 | 4,985 | 4,945 | 4,975 | +5 | +0.1% | 4,100 |
| 2017/12/07 | 4,950 | 4,980 | 4,950 | 4,970 | +20 | +0.4% | 1,200 |
1651～
1700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
